Amgen Stock Forecast for 2022 - 2025 - 2030

Updated on 09/30/2022

Stock Rating
9
Price Target
$255.00
Consensus
Neutral
Upside
11.64%
Analysts
13
Stock Rating
9
Upside
11.64%
Analysts
13
Price Target
$255.00

Amgen Stock Forecast and Price Target

Amgen's most recent price target of $255.00 for 2022 was provided by thridteen renowned analysts over the past few months, with an average prediction of $255.00. If this prediction is correct, Amgen's stock could rise by 11.64 percent from its current trading price. The potential increase for the stock is $255.00 per share, with a possible range of $182.00 to $295.00. If you are interested in AMGN stock, you should also look at its competitors.

$255.00

11.64% Upside

Hold
Hold

Amgen Fair Value Forecast for 2022 - 2025 - 2030

Amgen's Price has increased by 18.75% In the last three years, going from $197.71 to $234.78. In the next year, analysts expect Fair Value to reach $241.92 – an increase of 3.04%. For the next nine years, the forecast is for Fair Value to grow by 41.11%.

2022 Fair Value Forecast
$241.92
2023 Fair Value Forecast
$264.30
2024 Fair Value Forecast
$290.80
2025 Fair Value Forecast
$298.49
2026 Fair Value Forecast
$310.44
2027 Fair Value Forecast
$323.07
2028 Fair Value Forecast
$324.03
2029 Fair Value Forecast
$312.91
2030 Fair Value Forecast
$331.30
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
JNJ Stock Forecast Johnson & Johnson Outperform 12
$164.53 $185.07 10.62%
LLY Stock Forecast Eli Lilly and Outperform 16
$330.01 $333.19 6.06%
ROG Stock Forecast Roche Holding Outperform 18
CHF320.25 CHF384.23 17.10%
ABBV Stock Forecast AbbVie Outperform 9
$142.72 $164.23 9.30%
PFE Stock Forecast Pfizer Outperform 3
$44.16 $56.27 20.02%

Amgen Revenue Forecast for 2022 - 2025 - 2030

Amgen's Revenue has increased by 9.40% In the last three years, going from $23.75B to $25.98B. In the next year, analysts expect Revenue to reach $26.12B – an increase of 0.54%. For the next nine years, the forecast is for Revenue to grow by 7.99%.

2022 Rev Forecast
$26.12B
2023 Rev Forecast
$27.32B
2024 Rev Forecast
$28.62B
2025 Rev Forecast
$28.96B
2026 Rev Forecast
$29.35B
2027 Rev Forecast
$29.95B
2028 Rev Forecast
$29.64B
2029 Rev Forecast
$28.43B
2030 Rev Forecast
$28.05B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NOVO B Stock Forecast Novo Nordisk A/S Outperform 18
kr764.70 kr678.96 17.37%
MRK Stock Forecast Merck Outperform 6
$86.64 $99.57 15.42%
TMO Stock Forecast Thermo Fisher Scientific Outperform 18
$516.61 $658.24 30.66%

Amgen Dividend per Share Forecast for 2022 - 2025 - 2030

In the last three years, Amgen's Dividend per Share has grown, increasing from $5.28 to $7.04 – a growth of 33.33%. The next year looks promising for Amgen, with analysts predicting Dividend per Share of $7.61 – an increase of 8.10%. Over the next nine years, experts anticipate that Amgen's Dividend per Share will grow at a rate of 79.55%.

2022 DPS Forecast
$7.61
2023 DPS Forecast
$8.28
2024 DPS Forecast
$9.30
2025 DPS Forecast
$9.81
2026 DPS Forecast
$10.70
2027 DPS Forecast
$11.14
2028 DPS Forecast
$11.14
2029 DPS Forecast
$11.87
2030 DPS Forecast
$12.64
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
DHR Stock Forecast Danaher Outperform 16
$262.15 $321.60 23.97%
ABT Stock Forecast Abbott Laboratories Outperform 14
$98.29 $128.88 27.68%
AZN Stock Forecast AstraZeneca PLC Outperform 18
£99.33 £136.08 41.24%

Amgen Free Cash Flow Forecast for 2022 - 2025 - 2030

In the last three years, Amgen's Free Cash Flow has gone down from $10.56B to $8.38B – a 20.62% drop. Next year, analysts are expecting Free Cash Flow to reach $10.13B – an increase of 20.85%. Over the next nine years, the forecast is for Free Cash Flow to grow by 46.35%.

2022 FCF Forecast
$10.13B
2023 FCF Forecast
$10.40B
2024 FCF Forecast
$11.22B
2025 FCF Forecast
$11.38B
2026 FCF Forecast
$11.92B
2027 FCF Forecast
$12.85B
2028 FCF Forecast
$12.95B
2029 FCF Forecast
$12.66B
2030 FCF Forecast
$12.27B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
NOVN Stock Forecast Novartis Hold 18
CHF74.92 CHF103.75 18.89%
BMY Stock Forecast Bristol-Myers Squibb Outperform 2
$71.71 $79.05 15.74%
MDT Stock Forecast Medtronic Outperform 18
$82.27 $106.84 28.84%

Amgen Net Income Forecast for 2022 - 2025 - 2030

In the last three years, Amgen's Net Income has seen a drop from $8.39B to $5.89B – a 29.80% decrease. For the next year, analysts are expecting Net Income to reach $9.57B – an increase of 62.41%. Over the next nine years, experts predict that Net Income will grow by 67.17%.

2022 NI Forecast
$9.57B
2023 NI Forecast
$10.25B
2024 NI Forecast
$11.03B
2025 NI Forecast
$11.12B
2026 NI Forecast
$11.35B
2027 NI Forecast
$11.12B
2028 NI Forecast
$10.76B
2029 NI Forecast
$10.04B
2030 NI Forecast
$9.85B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
SAN Stock Forecast Sanofi Outperform 18
77.84€ 104.66€ 41.32%
GILD Stock Forecast Gilead Sciences Outperform 11
$63.07 $69.65 12.57%
VRTX Stock Forecast Vertex Pharmaceuticals Outperform 16
$292.80 $294.18 4.85%

Amgen EBITDA Forecast for 2022 - 2025 - 2030

In the last three years, Amgen's EBITDA has grown by 0.81%, rising from $12.48B to $12.58B. For next year, analysts predict EBITDA of $15.95B, which would mean an increase of 26.77%. Over the next nine years, experts predict that Amgen's EBITDA will grow at a rate of 4.03%.

2022 EBITDA Forecast
$15.95B
2023 EBITDA Forecast
$16.28B
2024 EBITDA Forecast
$16.97B
2025 EBITDA Forecast
$16.21B
2026 EBITDA Forecast
$15.23B
2027 EBITDA Forecast
$15.12B
2028 EBITDA Forecast
$15.25B
2029 EBITDA Forecast
$14.39B
2030 EBITDA Forecast
$13.09B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
REGN Stock Forecast Regeneron Pharmaceuticals Outperform 2
$691.82 $696.64 9.57%
ZTS Stock Forecast Zoetis Outperform 18
$150.95 $235.45 49.06%
MRK Stock Forecast MERCK Kommanditgesellschaft au... Outperform 18
163.60€ 147.51€ 28.36%

Amgen EBIT Forecast for 2022 - 2025 - 2030

In the last three years, Amgen's EBIT has decreased from $10.55B to $9.34B – a 11.50% drop. For next year, analysts predict EBIT of $12.42B, which would mean an increase of 33.01%. Over the next nine years, experts predict that Amgen's EBIT will grow at a rate of 35.96%.

2022 EBIT Forecast
$12.42B
2023 EBIT Forecast
$13.01B
2024 EBIT Forecast
$13.71B
2025 EBIT Forecast
$13.77B
2026 EBIT Forecast
$13.75B
2027 EBIT Forecast
$13.89B
2028 EBIT Forecast
$13.59B
2029 EBIT Forecast
$12.89B
2030 EBIT Forecast
$12.70B
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
MMM Stock Forecast 3M Hold 16
$112.30 $147.79 21.99%
GSK Stock Forecast GSK Outperform 16
£13.16 £16.08 38.30%
4568 Stock Forecast Daiichi Sankyo Company Outperform 18
¥4.03k ¥0.00 16.63%

Amgen EPS Price Prediction Forecast for 2022 - 2025 - 2030

Amgen's EPS has increased by 18.75% In the last three years, going from $14.40 to $17.10. In the next year, analysts expect EPS to reach $17.62 – an increase of 3.04%. For the next nine years, the forecast is for EPS to grow by 41.11%.

2022 EPS Forecast
$17.62
2023 EPS Forecast
$19.25
2024 EPS Forecast
$21.18
2025 EPS Forecast
$21.74
2026 EPS Forecast
$22.61
2027 EPS Forecast
$23.53
2028 EPS Forecast
$23.60
2029 EPS Forecast
$22.79
2030 EPS Forecast
$24.13
Ticker Name Consensus Stock Rating Price Price Target Upside/Downside
BAYN Stock Forecast Bayer Outperform 7
47.72€ 67.79€ 66.60%
4519 Stock Forecast Chugai Pharmaceutical Hold 18
¥3.63k ¥0.00 23.97%
4502 Stock Forecast Takeda Pharmaceutical Company Outperform 16
¥3.78k ¥0.00 16.53%